secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K
Filed at:   2023-11-17T23:59:59+00:00
Accession:  0001437749-23-032463
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Reviva raises $30M in registered direct offering of common stock and warrants
-----------------------------------------------------------------------------

- Offering of 5,853,660 shares (or pre-funded warrants) and 5,853,660 warrants at $5.125 per unit.
- Warrants exercisable at $5.00 per share, expire 5 years from issuance.
- Net proceeds expected ~$27.9M; director affiliate purchased $3M in pre-funded warrants.
- Proceeds to fund registrational Phase 3 RECOVER-2 trial and other R&D activities.
- Closing expected on or about November 20, 2023, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774923032463/0001437749-23-032463-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774923032463/rvph20231115_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-032463

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer